These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 796526)

  • 101. Liver damage induced by pyridinol carbamate.
    Litvin Y; Lubovsky E; Brezis M
    Lancet; 1977 Jun; 1(8024):1257. PubMed ID: 68350
    [No Abstract]   [Full Text] [Related]  

  • 102. [Angioprotectors in ophthalmology].
    Margolis MG
    Oftalmol Zh; 1979; 34(5):314-8. PubMed ID: 503433
    [No Abstract]   [Full Text] [Related]  

  • 103. [Phosphodiesterase-3 inhibitor].
    Kawagoe Y; Hattori Y; Kasai K
    Nihon Rinsho; 2010 Nov; 68 Suppl 9():186-9. PubMed ID: 21661155
    [No Abstract]   [Full Text] [Related]  

  • 104. [Preliminary study of a work concerning the activity of pyridinol carbamate on diabetic angiopathy (study of the microcirculation)].
    Le Devehat C; Lemoine A
    Journ Annu Diabetol Hotel Dieu; 1977; ():389-93. PubMed ID: 894879
    [No Abstract]   [Full Text] [Related]  

  • 105. [Pyridinolcarbamate (anginin) in the treatment of diabetic angiopathies].
    Tirkina TN; Aleksandrova LM; Kliachko VR; Mazovetskiĭ AG
    Ter Arkh; 1974; 46(1):107-10. PubMed ID: 4453966
    [No Abstract]   [Full Text] [Related]  

  • 106. [Influence of pyridinolcarbamate on platelet aggregation in diabetic subjects with ischemic cardiopathy].
    Citarrella P; Abbadessa V; Pecorella M; Cajozzo A
    Boll Soc Ital Cardiol; 1977; 22(7):1036-41. PubMed ID: 618239
    [No Abstract]   [Full Text] [Related]  

  • 107. Modifications of platelet retention in patients treated with pyridinolcarbamate. A preliminary report.
    Girolami A; Peruffo R; Emanueli A
    Arzneimittelforschung; 1977; 27(6):1202. PubMed ID: 578441
    [TBL] [Abstract][Full Text] [Related]  

  • 108. [Therapeutic activity of anti-platelet aggregation agents in arterial diseases].
    Delboy C; Jouve R; Escande M; Juhan I; Bouvenot G
    Sem Hop Ther; 1977 Nov; 53(9):431-40. PubMed ID: 341318
    [No Abstract]   [Full Text] [Related]  

  • 109. [Contribution of angioxine to the vascular protection of the diabetic].
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():319-27. PubMed ID: 796526
    [No Abstract]   [Full Text] [Related]  

  • 110. [Principles of conservative treatment of peripheral circulation disorders in diabetics].
    Wüstenberg PW
    Z Arztl Fortbild (Jena); 1972 Jan; 66(2):65-70. PubMed ID: 4554715
    [No Abstract]   [Full Text] [Related]  

  • 111. Clinical and metabolic profile in diabetic cardiovascular disease.
    Vaishnava H; Hagroo AA
    J Indian Med Assoc; 1973 Aug; 61(4):159-66. PubMed ID: 4590355
    [No Abstract]   [Full Text] [Related]  

  • 112.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 113.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 114.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 115.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 116.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 117.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 118.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 119.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 120.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 6.